You are here: Industry Insights > Internal Medicine

News List

Bedside, Outside-the-Room Case Presentation Compared drugs
June 29, 2021
Bedside case presentation is more efficient and results in similar patient knowledge about their medical care compared with outside-the-room case presentation, according to a study published online June 29 in the Annals of Internal Medicine.
Japanese regulators hand first global approval to AbbVie, Boehringer Ingelheim's IL-23 inhibitor Skyrizi firstwordpharma
March 27, 2019
AbbVie announced Tuesday that the Japanese Ministry of Health, Labour and Welfare approved Skyrizi (risankizumab) for the treatment of plaque psoriasis, generalised pustular psoriasis, erythrodermic psoriasis and psoriatic arthritis in adults who have an
Prognostic Bleeding Risk Models Developed for Aspirin Use drugs
February 26, 2019
Prognostic bleeding risk models that can estimate the absolute bleeding harms of aspirin have been developed for individuals in whom aspirin is being considered for primary prevention of cardiovascular disease (CVD)....
Single-Application FIT Moderately Sensitive, Specific for CRC drugs
February 26, 2019
Single-application fecal immunochemical tests (FITs) have moderate-to-high sensitivity and specificity for colorectal cancer (CRC), according to a review published online Feb. 26 in the Annals of Internal Medicine.
Tasly and Mesoblast Initiate Development and Regulatory Activities for MPC-150-IM Heart Failure Cell Therapy in China firstwordpharma
November 27, 2018
Tasly Pharmaceutical Group and Mesoblast Limited (Nasdaq:MESO; ASX:MSB) today announced that the first Joint Steering Committee (JSC) meeting for their cardiovascular partnership